What's on Tap at the Society of Hematologic Oncology's 10th Annual Meeting
Emphasis on novel biological approaches in treating patients with hematologic malignancies
Stay updated with breaking news from Alison Moskowitz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Emphasis on novel biological approaches in treating patients with hematologic malignancies
MedPage Today. "We didn't find any difference in response based on a patient's stage or burden of disease," she added. "The complete response rate was quite high, regardless of whether patients had primary refractory disease or relapsed disease, so I really think it's a reasonable approach to consider for anyone who has relapsed/refractory disease. I think the standard of care at this point would be to use a treatment like this as a bridge to an autotransplant, and studies looking at a nontransplant approach is really investigational at this point." As many as 25% patients with advanced-stage...